Key Statistics for COV
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (09/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (USD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for COV
- Net Income (M/USD)
Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
More Company Profile & Key Executives for COV
|Jose E Almeida "Joe"Chairman/President/CEO||Peter L WehrlyGroup Pres:Vascular Therepies|
|Charles J Dockendorff "Chuck"Exec VP/CFO||Mark C TrudeauSenior VP/Pres:Pharmaceuticals|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries